Thomas R Malley's Insider Trades & SAST Disclosures
Thomas R Malley's most recent trade in Kura Oncology Inc was a trade of 26,000 Option to purchase common stock done . Disclosure was reported to the exchange on June 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas R Malley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 19,040 | 19,040 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 9,373 (0%) | 0% | - | Class A Common Shares | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 3,173 | 3,173 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 5,000 (0%) | 0% | - | Class A Common Shares | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 0 | - | - | Restricted Share Units | |
| Kura Oncology Inc | Thomas R. Malley | Director | Purchase of securities on an exchange or from another person at price $ 11.50 per share. | 16 Jun 2023 | 50,000 | 139,557 (0%) | 0% | 11.5 | 575,000 | Common stock |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 26,236 | 26,236 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 4,373 | 4,373 | - | - | Restricted Share Units | |
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 30,000 | 30,000 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 5,000 | 5,000 | - | - | Restricted Share Units | |
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 33,237 | 33,237 | - | - | Share Option | |
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Kiniksa Pharmaceuticals Lt... | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 18,760 | 18,760 | - | - | Share Option | |
| Kura Oncology Inc | Thomas R. Malley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 23,000 | 23,000 | - | - | Option to purchase common stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges